Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geri Hirsch

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The International Journal on Drug Policy|March 5, 2013
Structural factors that promote stigmatization of drug users with hepatitis C in hospital emergency departmentsBarbara Paterson, Geri Hirsch, Karen Andres
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 19, 2011
Canada needs viral hepatitis action planKevork M Peltekian, Geri Hirsch, Carla Burgess
The International Journal on Drug Policy|September 15, 2007
The depiction of stigmatization in research about hepatitis CBarbara L Paterson, Markus Backmund, Geri Hirsch, et al.
Chronic Illness|May 29, 2009
Future directions for investigation of fatigue in chronic hepatitis C viral infectionKenneth Seaman, Barbara L Paterson, Michael Vallis, et al.
BMC Immunology|June 17, 2008
Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individualsLisa Barrett, Maureen Gallant, Constance Howley, et al.
Annals of Hepatology|October 25, 2006
Choroidal neovascularization with interferon associated retinopathy: case report and review of literatureSalem M Bazarah, Rusty Ritenour, Sunil T Patel, et al.
Immunology and Cell Biology|April 1, 2009
The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infectionTigran K Davtyan, Marine P Hovsepyan, Levon M Mkhitaryan, et al.
Transplantation|March 8, 2016
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" ExperienceNabiha Faisal, Marc Bilodeau, Bandar Aljudaibi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The International Journal on Drug Policy|March 5, 2013
Structural factors that promote stigmatization of drug users with hepatitis C in hospital emergency departmentsBarbara Paterson, Geri Hirsch, Karen Andres
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 19, 2011
Canada needs viral hepatitis action planKevork M Peltekian, Geri Hirsch, Carla Burgess
The International Journal on Drug Policy|September 15, 2007
The depiction of stigmatization in research about hepatitis CBarbara L Paterson, Markus Backmund, Geri Hirsch, et al.
Chronic Illness|May 29, 2009
Future directions for investigation of fatigue in chronic hepatitis C viral infectionKenneth Seaman, Barbara L Paterson, Michael Vallis, et al.
BMC Immunology|June 17, 2008
Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individualsLisa Barrett, Maureen Gallant, Constance Howley, et al.
Annals of Hepatology|October 25, 2006
Choroidal neovascularization with interferon associated retinopathy: case report and review of literatureSalem M Bazarah, Rusty Ritenour, Sunil T Patel, et al.
Immunology and Cell Biology|April 1, 2009
The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infectionTigran K Davtyan, Marine P Hovsepyan, Levon M Mkhitaryan, et al.
Transplantation|March 8, 2016
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" ExperienceNabiha Faisal, Marc Bilodeau, Bandar Aljudaibi, et al.
Pageof 1